Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives
January 14, 2018 21:12 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO Japan, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the...
Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership
December 12, 2017 17:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and TOKYO, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development...
Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange
November 14, 2017 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of...
Telix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET Technology
September 19, 2017 21:46 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and SAN FRANCISCO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company) is pleased to announce the conclusion of a collaboration and licensing...
Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited
September 17, 2017 18:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been...
Cyclotek and Telix Pharmaceuticals Conclude Radiopharmaceutical Manufacturing Agreement for Australia and New Zealand
July 31, 2017 00:59 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, July 31, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”) is pleased to announce the completion of a Master Services Agreement (“MSA”) with Cyclotek (Aust) Pty...
Radiopharmaceutical Regional Markets to See Double-Digit Growths, Reports BCC Research
January 26, 2017 05:00 ET
|
BCC Research
Wellesley, Mass, Jan. 26, 2017 (GLOBE NEWSWIRE) -- A growing and aging population, increasing life expectancy, and improved diagnostic modalities are key factors in market growth for...
Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC
October 17, 2016 07:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Radiopharmaceuticals Market surging at 18.3 % CAGR to touch US$12.2 bn by 2018; Strontium/Rubidium Generators Device segment Highly Influencing the Market Shares - TMR
August 12, 2016 05:48 ET
|
Transparency Market Research
Albany, NY, Aug. 12, 2016 (GLOBE NEWSWIRE) -- The global radiopharmaceuticals market is projected to grow at a high CAGR of 18.3 % to comprise a market worth US$12.2 bn by the end of 2018. The...
Advanced Accelerator Applications Expands its Presence in Germany with Strategic Acquisition of Two Production Sites
May 26, 2016 11:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, May 26, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (“AAA” or “the Company”) (Nasdaq:AAAP), an international specialist in Molecular Nuclear...